RGAHX
Price
$87.29
Change
-$0.28 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
VLLIX
Price
$51.22
Change
-$0.89 (-1.71%)
Updated
Jun 2 closing price
Net Assets
468.91M
Interact to see
Advertisement

RGAHX vs VLLIX

Header iconRGAHX vs VLLIX Comparison
Open Charts RGAHX vs VLLIXBanner chart's image
RGAHX vs VLLIX Comparison Chart in %
View a ticker or compare two or three
VS
RGAHX vs. VLLIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a Hold and VLLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 338B vs. VLLIX (469M). RGAHX pays higher dividends than VLLIX: RGAHX (0.39) vs VLLIX (0.00). RGAHX was incepted earlier than VLLIX: RGAHX (11 years) vs VLLIX (11 years). VLLIX (1.22) is less costly to investors than RGAHX (0.44). VLLIX is a more actively managed with annual turnover of: 38.00 vs. RGAHX (32.00). RGAHX has a lower initial minimum investment than VLLIX: RGAHX (250) vs VLLIX (100000). VLLIX annual gain was more profitable for investors over the last year : 26.22 vs. RGAHX (15.06). VLLIX return over 5 years is better than : 30.60 vs. RGAHX (25.77).
RGAHXVLLIXRGAHX / VLLIX
Total Expense Ratio0.440.8850%
Annual Report Gross Expense Ratio0.441.2236%
Fund Existence11 years11 years-
Gain YTD10.51213.79776%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets338B469M72,068%
Annual Yield % from dividends0.390.00-
Returns for 1 year15.0626.2257%
Returns for 3 years54.07108.8950%
Returns for 5 years25.7730.6084%
Returns for 10 years113.2697.38116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDY618.819.34
+1.53%
Teledyne Technologies
SKLZ10.040.04
+0.40%
Skillz
RAY3.37-0.01
-0.30%
Raytech Holding Limited
ITRI83.84-0.95
-1.12%
Itron
EVMN19.82-2.35
-10.60%
Evommune Inc.